Skip to main content

Table 2 Clinicopathological characteristics of the cohort included in the study (n = 213)

From: Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples

Characteristic Control cohort Cancer cohort
n = 136 n = 77
Age (years)
Mean (range) 50.4 (23–88) 66.4 (47–86)
Sex, no. (%)
Male 72 (52.9) 65 (84.4)
Female 64 (47.1) 12 (15.6)
Ethnicity, no. (%)
Caucasian 100 (73.5) 74 (96.1)
Asian 22 (16.2) 2 (2.6)
African-American 3 (2.2) 0 (0)
Hispanic 1 (0.7) 1 (1.3)
Other 0 (0) 0 (0)
Not available 10 (7.4) 0 (0)
Tumor type, no. (%)
NMIBC, TCC n.a 66 (85.7)
MIBC, TCC n.a 10 (13.0)
AC n.a 1 (1.3)
SCC n.a 0 (0)
Tumor grade, no. (%)
Low grade n.a 10 (13.0)
High grade n.a 51 (66.2)
Not Available n.a 16 (20.8)
  1. NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer, TCC transitional cell carcinoma, AC adenocarcinoma, SCC squamous cell carcinoma, n.a. not applicable